Related Experiment Video
Updated: May 9, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
The Austrian e-Medikation pilot evaluation: lessons learned from a national medication list
Stefan Janzek-Hawlat1, Elske Ammenwerth, Wolfgang Dorda
1Section for Medical Information Management and Imaging, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Austria.
Studies in Health Technology and Informatics
|August 8, 2013
Summary
The Austrian e-Medikation pilot project shows potential for improving patient safety through a national medication list and central checks. However, system improvements are needed before routine use, with 34 recommendations guiding future development.
Area of Science:
- Health Informatics
- Digital Health
- Medication Management
Background:
- The Austrian e-Medikation project aimed to establish a national digital medication list and central checking system.
- Previous medication management systems lacked comprehensive national integration and real-time data sharing.
Purpose of the Study:
- To evaluate the Austrian e-Medikation pilot project.
- To gather user feedback and identify areas for improvement in the national medication list and central checking system.
Main Methods:
- Log-file analysis of system usage.
- Surveys distributed to participating physicians, pharmacists, and patients.
- Involved 97 physicians, 58 pharmacies, and over 5,000 patients.
Main Results:
- All user groups recognized e-Medikation's potential to enhance patient safety.
- Identified issues with software quality and system architecture hindering routine implementation.
- Generated 34 specific recommendations for system enhancement and rollout.
Conclusions:
- e-Medikation holds promise for improving medication safety in Austria.
- Further development is required to address technical limitations before widespread adoption.
- Recommendations have informed the development of the Austrian electronic health record system, ELGA.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...